Seroprevalence rates of rubella virus antibodies among pregnant women

The information is intended to provide an indication of population immunity, based on antibody testing results in antenatal serum specimens received during the designated year.

Year	Age group (years)
	<20		20-24		25-29		30-34		>34
	No. tested	%	No. tested	%	No. tested	%	No. tested	%	No. tested	%
2001	749	96.5	4001	91.1	9042	91.6	7582	92.1	4332	89.9
2002	551	95.5	3338	90.4	9979	91.6	7036	92.1	3799	91.8
2003	427	95.3	2215	92.0	5483	91.4	4991	91.3	2674	90.3
2004	625	94.6	3918	91.8	8925	91.3	9061	90.7	4462	90.3
2005	594	92.8	4043	90.7	8087	89.8	9441	91.1	4925	89.5
2006	660	91.5	3800	90.3	8143	90.4	10036	91.2	5292	89.1
2007	616	91.5	3453	90.9	8185	92.4	11065	92.4	6128	89.7
2008	602	89.0	3419	92.5	8527	92.5	11096	91.8	6365	89.8
2009	509	95.7	3346	90.1	8339	91.7	10929	91.8	6672	89.3
2010	538	84.8	3406	90.3	8800	92	11025	92.5	7187	90
2011	447	89.4	2898	90.9	9010	93.6	12273	94	7552	91.7
2012	510	85.3	2653	91.2	8640	93.9	13340	94.8	8113	91.5
2013	480	82.3	2363	89.3	7960	94.8	13106	95.9	7776	93
2014	410	85.3	2408	87.5	8387	94	14235	95.5	8408	92.3
2015	426	85.7	2385	87.9	8246	93.6	13860	96.1	8472	94.3
2016	368	87.8	2251	85.3	8034	92.9	13756	95.9	8499	94.8
2017	311	87.1	2021	82.6	7009	90.5	12195	95.8	8267	94.8
2018	260	85.8	1822	82.1	6771	88.2	12326	95.7	8620	95.2
2019	218	88.1	1588	83.6	6303	87.8	12077	95.1	8400	95.1
2020	177	95.5	1105	90.2	4576	92.6	9708	95.9	6766	95.1
2021	133	96.2	903	91	4254	91.5	9243	95.5	6797	95.8
2022	113	96.5	712	91.4	3582	90.8	8140	95	6055	95.4
2023	81	90.1	711	91.3	3644	89.7	8703	92.5	6618	94.7
2024	92	92.4	649	91.4	3354	87.5	8221	91.1	6717	94.0